Oxybuprocaine hydrochloride NEW
| Price | $37 | $50 | $62 |
| Package | 10mg | 25mg | 50mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2024-11-19 |
Product Details
| Product Name: Oxybuprocaine hydrochloride | CAS No.: 5987-82-6 |
| Purity: 99.87% | Supply Ability: 10g |
| Release date: 2024/11/19 |
Product Introduction
Bioactivity
| Name | Oxybuprocaine hydrochloride |
| Description | Oxybuprocaine hydrochloride (Oxybuprocaine HCl), a local anesthetic, is used especially in otolaryngology and ophthalmology. |
| In vivo | Similar to bupivacaine or lidocaine, Oxybuprocaine produces dose-related spinal cord blockade of proprioception, locomotion, and injury perception.Oxybuprocaine binds to sodium channels and reversibly stabilizes neuronal cell membranes to make them less permeable to sodium ions.Oxybuprocaine inhibits the depolarization of neuronal cell membranes, thereby Oxybuprocaine inhibits the depolarization of neuronal cell membrane, thus blocking the initiation and conduction of nerve impulses. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | Ethanol : 64 mg/mL (185.6 mM) H2O : 63 mg/mL (182.7 mM) DMSO : 64 mg/mL (185.6 mM) |
| Keywords | sclera | disease | ophthalmology | cornea | Oxybuprocaine hydrochloride | Oxybuprocaine Hydrochloride | Benoxinate | ALO | Oxybuprocaine | otolaryngology | painful | propagation | Inhibitor | Na channels | Na+ channels | Parkinson’s | Sodium Channel | nerve | inhibit | impulses | conjunctiva |
| Inhibitors Related | Phenytoin sodium | Lidocaine | Valproic Acid | Lidocaine hydrochloride | L-Aspartic aicd sodium | Mebeverine hydrochloride | Amitriptyline hydrochloride | Riluzole | Benzocaine | Nefopam hydrochloride |
| Related Compound Libraries | Pain-Related Compound Library | Bioactive Compound Library | Membrane Protein-targeted Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Neuroprotective Compound Library | Inhibitor Library | Anti-Cancer Approved Drug Library | Bioactive Compounds Library Max | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $37.00/10mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2024-11-19 | |
| $19.10/1KG |
VIP4Y
|
Hebei Chuanghai Biotechnology Co,.LTD
|
2024-08-09 | |
| $99.00/25kg |
Ouhuang Engineering Materials (Hubei) Co., Ltd
|
2024-04-12 | ||
| $40.00/1kg |
VIP5Y
|
Hebei Yanxi Chemical Co., Ltd.
|
2023-09-07 | |
| $50.00/1kg |
Henan Bao Enluo International TradeCo.，LTD
|
2023-07-25 | ||
| $88.00/1KG |
Xiamen Wonderful Bio Technology Co., Ltd.
|
2023-07-21 | ||
| $15.00/1KG |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-10 | ||
| $3.00/1KG |
VIP6Y
|
Career Henan Chemical Co
|
2020-01-18 | |
| $15.00/1KG |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-09 |
United States- Since: 2011-01-07
- Address: 36?Washington?Street, Wellesley?Hills
INQUIRY